Table 1 A list of essential medicines for COPD treatment according to China COPD guidelines8.

From: The availability of drugs for stable COPD treatment in China: a cross-sectional survey

 

Drug category

Name

Inhaled drugs

Monotherapy

SABA

Terbutaline

Salbutamol

LABA

Indacaterol

SAMA

Ipratropium bromide

LAMA

Glycopyrronium bromide

Tiotropium Bromide

Double therapy

LAMA/LABA

G/F

G/I

U/V

T/O

ICS/LABA

Be/F

Bu/F (320ug/9ug, 160ug/4.5ug, 80ug/4.5ug)

F/S (500ug/50ug, 250ug/50ug, 100ug/50ug)

Triple therapy

ICS/LAMA/LABA:

B/G/F

F/U/V

Oral drugs

 

Expectorants

Erdosteine

N-acetylcysteine

Carbocysteine

Fudosteine

Ambroxol

Theophylline

Aminophylline

Antibiotics

Bacterial lysates

Azithromycin

Bacterial lysates

  1. Roflumilast, Levalbuterol and Fluticasone/Vilanterol (F/V) are not included in this survey because they are almost commercially unavailable in China.
  2. SABA short-acting β2 agonist, LABA long-acting β2 agonist, SAMA short-acting antimuscarinics, LAMA long-acting antimuscarinics, G/F glycopyrrolate/formoterol, G/I glycopyrrolate/indacaterol, U/V umeclidinium/vilanterol, T/O tiotropium/olodaterol, ICS inhaled corticosteroids, Be/F beclometasone/formoterol, Bu/F budesonide/formoterol, F/S fluticasone/salmeterol, B/G/F budesonide/glycopyrronium/formoterol, F/U/V fluticasone/umeclidinium/vilanterol.
Back to article page